Skip to main content
SpringerLink
Log in

BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

B cell translocation gene 3 (BTG3) is a tumor suppressor by inhibiting cell proliferation, migration, and regulating cell cycle progression in several tumors. However, its role in esophageal adenocarcinoma (EAC) remains unknown. Here, we detected the expression of BTG3 in EAC tissues and subsequent progression. BTG3 expression was significant decreased in EAC tissues and cell lines detected by real-time RT–PCR and Western blot. Relationships of BTG3 with EAC clinicopathology were analyzed statistically. The decrease expression of BTG3 is associated with lymph node metastases. In vitro assay demonstrated that overexpression of BTG3 significantly suppressed colony formation and proliferation of EAC cells. The suppressed migration and invasion abilities found in BTG3-overexpressing EAC cells. Our findings suggested that BTG3 is suppressor in the progression of EAC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013) Oesophageal carcinoma. Lancet 381:400–412

    Article  PubMed  Google Scholar 

  2. Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146

    Article  PubMed  Google Scholar 

  3. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer Group (2013) The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258:500–507

    Article  PubMed  Google Scholar 

  4. Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627–1633

    PubMed  Google Scholar 

  5. Li X, Galipeau PC, Paulson TG, Sanchez CA, Arnaudo J, Liu K, Sather CL, Kostadinov RL, Odze RD, Kuhner MK, Maley CC, Self SG, Vaughan TL, Blount PL, Reid BJ (2014) Temporal and spatial evolution of somatic chromosomal alterations: a case-cohort study of Barrett’s esophagus. Cancer Prev Res 7:114–127

    Article  Google Scholar 

  6. Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67–72

    Article  CAS  PubMed  Google Scholar 

  7. Winkler GS (2010) The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222:66–72

    Article  CAS  PubMed  Google Scholar 

  8. Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, Tsuzuku JK, Yamamoto T, Hayashi S, Nagasawa K, Sueoka E (2003) Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202:71–79

    Article  CAS  PubMed  Google Scholar 

  9. Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Yamamoto T, Miyauchi A (2005) Phosphorylation and inactivation tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 220:237–242

    Article  CAS  PubMed  Google Scholar 

  10. Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA, Walden PD (2001) Antiproliferative B cell translocation gene 2 protein is down-regulated post transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 22:1271–1279

    Article  CAS  PubMed  Google Scholar 

  11. Kawakubo H, Brachtel E, Hayashida T, Yeo G, Kish J, Muzikansky A, Walden PD, Maheswaran S (2006) Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein. Cancer Res 66:7075–7082

    Article  CAS  PubMed  Google Scholar 

  12. Ou YH, Chung PH, Hsu FF, Sun TP, Chang WY, Shieh SY (2007) The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J 26:3968–3980

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S, Sudo K, Iwakura Y, Shibutani M, Mitsumori K, Yokota J, Yamamoto T (2009) Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci 100:225–232

    Article  CAS  PubMed  Google Scholar 

  14. Majid S, Dar AA, Ahmad A, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R (2009) BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 30:662–667

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Lin TY, Cheng YC, Yang HC, Lin WC, Wang CC, Lai PL, Shieh SY (2012) Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis. Oncogene 31:3287–3297

    Article  CAS  PubMed  Google Scholar 

  16. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R (2010) Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 116:66–76

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Chen XB, Chen GY, Cao XG, Zhou YD, Yang TJ, Wei SD (2013) Downregulation of BTG3 in non-small cell lung cancer. Biochem Biophys Res Commun 437:173–178

    Article  CAS  PubMed  Google Scholar 

  18. Deng BY, Zhao Y, Gou WF, Chen S, Mao XY, Takano Y, Zheng HC (2013) Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma. Tumor Biol 34:2617–2624

    Article  Google Scholar 

  19. Ren XL, Zhu XH, Li XM, Li YL, Wang JM, Wu PX, Lv ZB, Ma WH, Liao WT, Wang W, Ding YQ, Liang L (2015) Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer. J Cancer Res Clin Oncol 141:397–405

  20. Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV (2006) A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 20:236–252

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68:4123–4132

    Article  CAS  PubMed  Google Scholar 

  22. Yanagie H, Tanabe T, Sumimoto H, Sugiyama H, Matsuda S, Nonaka Y, Ogiwara N, Sasaki K, Tani K, Takamoto S, Takahashi H, Eriguchi M (2009) Tumor growth suppression by adenovirus-mediated introduction of a cell growth suppressing gene tob in a pancreatic cancer model. Biomed Pharmacother 63:275–286

    Article  CAS  PubMed  Google Scholar 

  23. Farioli-Vecchioli S, Tanori M, Micheli L, Mancuso M, Leonardi L, Saran A, Ciotti MT, Ferretti E, Gulino A, Pazzaglia S, Tirone F (2007) Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J 21:2215–2225

    Article  CAS  PubMed  Google Scholar 

  24. Molinari M (2000) Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif 33:261–274

    Article  CAS  PubMed  Google Scholar 

  25. Cheng YC, Lin TY, Shieh SY (2013) Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1. Proc Natl Acad Sci USA 110:5993–5998

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Deng B, Zhao Y, Gou W, Chen S, Mao X, Takano Y, Zheng H (2013) Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma. Tumour Biol 34:2617–2624

    Article  PubMed Central  PubMed  Google Scholar 

  27. Lv Z, Zou H, Peng K, Wang J, Ding Y, Li Y, Ren X, Wang F, Chang R, Liang L, Ding Y (2013) The suppressive role and aberrant promoter methylation of BTG3 in the progression of hepatocellular carcinoma. PLoS ONE 8:e77473

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Basic Medical Sciences, Zhengzhou University, No. 100 Kexue Road, Zhengzhou, 450001, China

    Yuwen Du, Pingping Liu, Wenqiao Zang, Yuanyuan Wang, Xiaonan Chen, Min Li & Guoqiang Zhao

Authors
  1. Yuwen Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pingping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenqiao Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuanyuan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaonan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Min Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guoqiang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guoqiang Zhao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Du, Y., Liu, P., Zang, W. et al. BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma. Mol Cell Biochem 404, 31–38 (2015). https://doi.org/10.1007/s11010-015-2363-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-015-2363-9

Keywords

Search

Navigation